Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Status: | Active, not recruiting |
---|---|
Conditions: | Colorectal Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 21 - Any |
Updated: | 4/17/2018 |
Start Date: | November 2016 |
End Date: | September 2020 |
Efficacy and Safety of LifeSeal™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study
LifeSeal™ Kit, surgical sealant designed for staple-line reinforcement that is applied over
the anastomotic line to prevent bowel content leakage until full physiological function is
restored.
RATIONALE : Postoperative anastomotic leakage is one of the most devastating and feared
complications in colorectal surgery. The risk of postoperative anastomotic leakage varies
widely depending on the level of anastomosis while the risk is higher in low anastomosis.
In order to best demonstrate the benefits of LifeSeal™ in providing staple line reinforcement
and helping to reduce leaks, the study includes high risk anastomoses, defined as colorectal
and coloanal anastomoses performed within 10 cm from the anal verge.
STUDY DESIGN: This study is designed as a prospective, multi-center, multinational
randomized, single-blind, double armed study PRIMARY OBJECTIVE: The primary objective of this
study is to assess the efficacy and safety of LifeSeal™ Kit as measured by the change in
overall anastomotic leak rates in subjects undergoing low anterior resection with an
anastomosis below 10 cm from the anal verge, over the first 17 weeks after surgery.
SECONDARY OBJECTIVES: The secondary objective of this study is to assess the incidence of
post-operative leaks and additional benefits that could be related to the use of LifeSeal™
Kit such as reducing the severity and improving the outcome of a leak once it has occurred.
In addition, the study will allow for collection and analysis of additional safety data and
usability assessment of the device, medical resource utilization, and health related quality
of life measures.
the anastomotic line to prevent bowel content leakage until full physiological function is
restored.
RATIONALE : Postoperative anastomotic leakage is one of the most devastating and feared
complications in colorectal surgery. The risk of postoperative anastomotic leakage varies
widely depending on the level of anastomosis while the risk is higher in low anastomosis.
In order to best demonstrate the benefits of LifeSeal™ in providing staple line reinforcement
and helping to reduce leaks, the study includes high risk anastomoses, defined as colorectal
and coloanal anastomoses performed within 10 cm from the anal verge.
STUDY DESIGN: This study is designed as a prospective, multi-center, multinational
randomized, single-blind, double armed study PRIMARY OBJECTIVE: The primary objective of this
study is to assess the efficacy and safety of LifeSeal™ Kit as measured by the change in
overall anastomotic leak rates in subjects undergoing low anterior resection with an
anastomosis below 10 cm from the anal verge, over the first 17 weeks after surgery.
SECONDARY OBJECTIVES: The secondary objective of this study is to assess the incidence of
post-operative leaks and additional benefits that could be related to the use of LifeSeal™
Kit such as reducing the severity and improving the outcome of a leak once it has occurred.
In addition, the study will allow for collection and analysis of additional safety data and
usability assessment of the device, medical resource utilization, and health related quality
of life measures.
Inclusion Criteria:
1. Male or female ≥ 21 years of age at Screening Visit.
2. Written informed consent obtained from subject or subject's legal representative and
ability for subject to comply with the requirements of the study.
3. Subject is diagnosed with colorectal cancer
4. Subject is scheduled for elective open, laparoscopic or robot assisted surgery
involving the creation of a circular stapled anastomosis created within 10cm from the
anal verge.
5. Procedure involving Total Mesorectal Excision by an abdominal or transanal approach.
6. Female subjects in child bearing age must be using acceptable contraception methods
such as hormonal contraception or two forms of barrier contraception. Acceptable
contraception must be used consistently from 30 days before screening until 3 years
following surgery
Exclusion Criteria:
Pre-operative exclusion criteria:
1. Female subject who is pregnant, breastfeeding, or if of child bearing potential is
unwilling to practice birth control until 3 years following surgery.
2. Presence of a condition or abnormality that in the opinion of the Investigator would
compromise the safety of the subject or the quality of the data.
3. Subject has a history of hypersensitivity to porcine derived gelatin or collagen.
4. Subject has a history of hypersensitivity to microbial Transglutaminase.
5. Subject has a known dysfibrinogenemia, hypofibrinogenemia or a fibrinogenemia, without
preoperative correction of fibrinogen levels.
6. Subject participating in any other study involving an investigational (unapproved)
drug or device within the past 60 days.
7. Subject participating in studies involving approved drug or device will be enrolled
only following a mutual consideration of the investigator together with the Sponsor.
8. Subject with a BMI ≥50, which may interfere with access to the surgical site and
increase overall operative risk.
9. Subject with American Society of Anesthesiology (ASA) status higher than 3.
10. Avastin use within 30 days prior to surgery.
11. Subject who has undergone a prior pelvic anastomosis.
12. Subject is scheduled for another surgery during the first 6 months following surgery
(not including stoma closure ,placement of port for chemotherapy or ureter stent
insertion).
13. Subject with an active abdominal or pelvic infection at the operation site.
14. Subject has been previously treated with LifeSeal™ Surgical Sealant.
Intra-operative Exclusion Criteria
1. Anastomosis or procedure (TME) was performed differently from what was defined in the
inclusion criteria.
2. Subject received intra-operative sealant, glue or any buttressing material other than
the LifeSeal™ Surgical Sealant.
3. Subject has peritoneal carcinomatosis.
4. Subject requires additional unrelated anastomosis during the surgery.
5. Subject is going through another surgical procedure (other than ileostomy or
adhesiolysis) during the surgery.
6. Excessive bleeding (above 500cc) identified prior to anastomosis formation with the
need for intra-operative blood transfusion.
We found this trial at
24
sites
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
University of Vermont The University of Vermont combines faculty-student relationships most commonly found in a...
Click here to add this to my saved trials
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
Indiana University INDIANA UNIVERSITY is a major multi-campus public research institution, grounded in the liberal...
Click here to add this to my saved trials
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
Click here to add this to my saved trials
Cleveland Clinic Florida Cleveland Clinic Florida, located in Weston, West Palm Beach, Palm Beach Gardens...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
Click here to add this to my saved trials
New York University More than 175 years ago, Albert Gallatin, the distinguished statesman who served...
Click here to add this to my saved trials
Click here to add this to my saved trials
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials